An Indian Multicentric, Open Label, Prospective Phase IV Study of Bevacizumab in the Front Line Management of Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer in Real-Life Clinical Practice First published 10/09/2013 Last updated 26/05/2026 EU PAS number:EUPAS3724 Study Finalised